Related Experiment Video
Updated: Sep 9, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Enhancing patient stratification methods for medication review during acute admissions
Louise Westberg Strejby Christensen1,2,3, Helle Gybel Juul-Larsen1, Line Jee Hartmann Rasmussen1,4
1Department of Clinical Research, Copenhagen University Hospital Amager and Hvidovre, Hvidovre, Denmark.
Identifying high-risk patients for hospital medication review is crucial. A frailty index (FI-OutRef) or suPAR levels better predict adverse outcomes than traditional methods, improving patient selection for medication review.
Area of Science:
- Clinical Pharmacy
- Geriatric Medicine
- Internal Medicine
Background:
- Hospital medication reviews identify inappropriate prescribing but resource limits necessitate targeted patient selection.
- Current patient stratification relies on medication count and age, potentially missing high-risk individuals.
- Predicting adverse clinical outcomes like readmission or mortality is key for efficient medication review targeting.
Purpose of the Study:
- To explore if clinical factors beyond medication count and age can improve prediction of adverse clinical outcomes in acutely hospitalized medical patients.
- To identify novel biomarkers or indices for better patient stratification for medication review.
Main Methods:
- An exploratory study analyzed data from 27,873 acutely admitted medical patients (≥18 years) at Copenhagen University Hospital Hvidovre.
- Outcomes assessed were acute readmission or mortality within 90 days post-discharge.
- Predictive models compared traditional factors (medication count, age) with medication risk score (MERIS), renal function, anticholinergic burden, a frailty index (FI-OutRef), and plasma soluble urokinase plasminogen activator receptor (suPAR).
Main Results:
- Neither MERIS, renal function, nor anticholinergic burden improved outcome prediction compared to medication count and age.
- Incorporating a frailty index (FI-OutRef) or suPAR significantly enhanced the prediction of 90-day adverse clinical outcomes.
- These findings suggest FI-OutRef and suPAR are valuable for identifying patients who would benefit most from medication review.
Conclusions:
- Frailty index (FI-OutRef) and suPAR are superior predictors of adverse clinical outcomes in hospitalized medical patients compared to traditional factors.
- These biomarkers offer practical proxies of disease burden for improved patient stratification for medication review.
- Optimizing medication review targeting can enhance patient safety and resource allocation in hospitals.
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
11:02Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Related Concept Videos
Drug Therapy
Antianxiety Medications
Factors Affecting Drug Response: Overview
Psychosis: Goals of Pharmacotherapy
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...